Scientific Programme
You
can download a pdf with the program at the bottom of this
page
Monday
20th September
08.30
Registration
09.30
Welcome - L.M. Kortbeek (The
Netherlands) and R.C.A. Thompson (Australia)
09.45
Opening Lecture - Leeuwenhoek’s revelations
B.J. Ford (United Kingdom)
10.45
Break
Taxonomy & Nomenclature
Chair: R.C.A. Thompson (Australia)
11.15
Giardia: Genetic change
and constancy
R.A. Adam
(USA)
11.45
Developments in taxonomy
M. Tibayrenc
(France)
12.15
Discussion
Chair: R.C.A. Thompson (Australia)
13.30
Molecular epidemiology of human infections caused by
Cryptosporidium and Giardia
S.M. Caccio (Italy)
14.00
Giardia and Cryptosporidium of wild and zoo
mammals
A. Appelbee (Canada)
14.30
Molecular identification
of human Giardia strains from The Netherlands and phylogenetic
analysis using 18S-RDNA and GDH sequences
J.G.M. van der Giessen
(The Netherlands)
14.50
Development of an RT-PCR method for detection and
differentiation of Cryptosporidium species of public health
concern
C.M. Read (Australia)
15.10
Detection and genotyping of Giardia duodenalis from human and
animal isolates in Italy
F. Berrilli
(Italy)
16.00
Poster presentation
Tuesday 21nd
September
New technologies
Chair: A. Appelbee (Canada) and T.G. Mank (The
Netherlands)
09.00
Emerging technologies for
the detection and genetic characterisation of Cryptosporidium and
Giardia
P. Monis (Australia)
09.30
Molecular techniques for genotyping Cryptosporidium and
Giardia isolates
S. Caccio (Italy)
10.00
Development of a novel genetic fingerprinting method for
Giardia lamblia
R. Jansen (The Netherlands)
10.15
A novel genotyping method for Cryptosporidium spp.: current
status of mixed infection with different genotypes
M.
Tokoro (Japan)
Chair: A. Appelbee (Canada) and T.G. Mank (The
Netherlands)
11.00
Genetic Characterization by random amplified polymorphic DNA
analysis(RAPD) of 18
isolates of Giardia lamblia obtained from day care children.
Description of a genetic
marker of pathogenicity
L.
de los Angeles Pelayo Duran (Cuba)
11.20
Cryptosporidiosis in Zambian patients with diarrhoea:
Molecular and clinical
characterization
A. Ayoub (United
Kingdom)
11.40
Molecular typing of Crytosporidium and Giardia in Danish
cattle and pig herds
R.B. Langkjaer
(Denmark)
12.00
Database development of Giardia and Cryptosporidium for
phylogenetic analysis
A. de Vries (The Netherlands)
Chair: J.G.M. van der Giessen (The Netherlands) and B.R.
Dixon (Canada)
13.45 The Zoonotic Significance
of Giardia and Cryptosporidium
R.C.A. Thompson (Australia)
14.15 Genetic
comparison between Giardia isolates of human and animal origin by
PCR-RFLP in Iran: Evidence of zoonotic transmission
M. Rezaeian (Iran)
14.35 Giardia and
Cryptosporidium in the intestinal contents of ringed seals and
bearded seals in Nunavik, Quebec, Canada
B.R. Dixon
(Canada)
15.00
Parallel workshops
Workshop
Molecular typing
Workshop Other waterborne
protozoa
Chair: P. Karanis
(Germany)
Waterborne
transmission of protozoan parasites: a review of worldwide
outbreaks
P. Karanis (Germany)
Combined
flocculation with nested-pcr for the detection of Toxoplasma gondii
in water
P. Karanis
(Germany)
Isolation and identification of free-living amoebae
from drinking water sources collected in western Japan.
A.
Kimura (Japan)
How do Acanthamoeba cross the blood-brain barrier to
produce granulomatous amoebic encephalitis
Naveed Ahmed Khan
(United Kingdom)
Balamuthia mandrillaris: an increasingly important
pathogen
Naveed Ahmed Khan (United Kingdom)
Clinical and environmental distribution of
Acanthamoeba spp. in Iran
Amir Hossein Maghsood
(Iran)
Detection of Cyclospora and Isospora from diarrheal feces and tap
water collected from Nepal and Lao PDR
K. Kimura
(Japan)
Wednesday 22nd September
Chair: T. Paget (United Kingdom)
09.00
Control of Giardia and Cryptosporidium infections in
humans
09.30
Control of Giardia and
Cryptosporidium infections in animals
M. Olson
(Canada)
10.00
Prevention and Control of
Cryptosporidium and Giardia in the Environment
R.
Fayer (USA)
10.30
Break
Chair: T. Paget (United
Kingdom)
11.00
Characterization of S-adenosyl-L-homocysteine hydrolase gene
from Cryptosporidium: assessment of drug candidates against
cryptosporidiosis
M.
Tokoro (Japan)
11.20
Genotype-linked metronidazole sensitivity of clinical Giardia
duodenalis isolates
L.
Favennec (France)
11.40
A high level of albendazole resistance in vitro involves
multidrug resistance in Giardia
G.
Ortega – Pierres (Mexico)
13.30
Diagnostic possibilities in human infections
T.G. Mank (The Netherlands)
14.00
Validation of flow cytometry for the detection of Giardia and
Cryptosporidium spp. in bovine fecal samples: preliminary
results
F. Uehlinger (Canada)
14.20
Multiplex detection of
Entamoeba histolytica, Giardia lamblia and Cryptosporidium parvum in
faecal samples using real-time PCR
J. Verweij (The
Netherlands)
14.40
Detection of Giardia lamblia in stool samples at people in
collective accommodation
N. Miladinovic-Tasic (Serbia and
Montenegro)
Clinical presentations
Chair: L.M. Kortbeek (The Netherlands)
15.00
Giardiasis, clinical presentation and
therapy
J.J.M. Tolboom (The Netherlands)
15.30
Cryptosporidiosis clinical presentation and
therapy
V. Kartashev (Russia)
16.00
Break
Clinical presentations continued
Chair: L.M. Kortbeek (The Netherlands)
16.30 The
prevalence and correlation of Giardiasis with the nutritional status
of primary school students in Iran - Esfahan
M. Azami
(Iran)
16.50
Giardia lamblia: different genotypes, different
symptoms?
T.G. Mank (The Netherlands)
17.10
Cryptosporidium infection in Kala azar patients in
Sudan
G. Elfadil
(Sudan)
19.30
Conference dinner
Thursday 23rd September
Epidemiology
Chair: L.M.
Kortbeek (The Netherlands)
09.00
Epidemiology of Cryptosporidium and Giardia
P.R. Hunter (United Kingdom)
09.30
Giardia and Crypto; the Dutch situation
L.M. Kortbeek (The Netherlands) and T.G. Mank (The
Netherlands)
10.00
Investigating the public health significance of
Cryptosporidium in the environment
G. Robinson (United
Kingdom)
10.20
Estimation of characteristics of four diagnostic tests and
prevalence of Cryptosporidium spp. oocysts excretion by a Bayesian
approach on two Irish farms
V. De Waele (United Kingdom)
10.40
Giardia cysts and Cryptosporidium oocysts in
a surface watersource for human consumption in Viçosa, Minas Gerais
State, Brazil
P.D. Bevilacqua
(Brazil)
11.00
Break
Epidemiology continued
Chair: L.M. Kortbeek (The Netherlands)
11.30
Prevalence of Cryptosporidium infection of farm animals in
Kerman, Iran
M.
Fasihi Harandi (Iran)
11.50 Prevalence of
intestinal protozoal parasites in relation to HIV serostatus and
complains of chronic diarrhoea in Blantyre, Malawi
L. van Lieshout (The Netherlands)
12.10
Lunch with poster presentations
Thursday
afternoon: two parallel sessions
Cell Biology – parallel session 1
Chair: T.G. Mank (The Netherlands) and H. Smith (United Kingdom)
13.30
Encystment as a target for drug design
E.L. Jarroll (USA)
14.00
The protein secretory pathways and mitochondrial
remnants in Giardia and Cryptosporidium
P.
Köhler (Switzerland)
14.30
Apoptosis in Giardia: still more questions than
answers
N. Kitchener
14.50
Modulation of host polyamine biosynthetic enzymes by
Cryptosporidium parvum
N. Yarlett (USA)
15.10
Advances in the Developmental Biology of Cryptosporidium
N. Hijjawi (Australia)
15.30
Break
Chair: T. Paget (United
Kingdom)
16.00
Pathogenesis of Giardia and Cryptosporidium
A.G. Buret (Canada)
16.30
Altered gene expression during Giardia- host cell
interactions
K.
Roxström- Lindquist (Sweden)
16.50
Gut Cryptosporidium parvum (genotype II) infection of
unweaned immunocompetent rats results in long-terme jejunal
hypersensitivity to distension
R. Marion
(France)
Chair: G.J. Medema (The Netherlands)
13.30
Cryptosporidium
and Giardia in drinking water in Amsterdam
Y. Dullemont
14.00
Optimization of a purification plant for the detection of
Cryptosporidium and Giardia: A Rand Water Experience
M. Grundlingh (South Africa)
14.20
The effects of water treatment processes on Cryptosporidium
infectivity and disinfection
P. Monis (Australia)
14.40
Potential Cryptosporidium oocyst surrogates for sand
filtration and the importance of their surface properties
J. Chung (Australia)
15.00
Break
Chair: P. Hunter (United Kingdom)
15.30
Cryptosporidium and Giardia in swimming pools in the
Netherlands
C. Schets (The
Netherlands)
15.50
Assessing geospatial and geotemporal contamination of a
watershed with Cryptosporidium and Giardia using molecular forensic
profiling
N.F. Neumann (Canada)
16.10
Quantifying the impact of runoff events on Cryptosporidium
entering drinking source waters
R. Signor
(Australia)
Chair: P. Karanis
(Germany)
16.30
Effects of sewage effluent treatment processes on the
viability of Giardia muris cysts
D. Bowman (USA)
16.50
Cryptosporidium oocysts and Giardia cysts in
wastewater
L. Weaver (United Kingdom)
17.10
The occurrence and reduction of Giardia and Cryptosporidium
in sewage and sludge from six Swedish treatment plants with
Immunomagnetic separation/Immunofluorescens and Immunomagnetic
separation in combination with a nested Polymerase Chain
Reaction 
A. Hansen
(Sweden)
Beertour
(optional)
Friday 24th
September
Chair: H. Smith (United Kingdom)
09.00
Giardia and Crypto: challenges to the water
industry
G.J. Medema (The Netherlands)
09.30
Waterborne outbreaks of
Cryptosporidium and Giardia infections
P.R. Hunter (United Kingdom)
10.00
Risk evaluation and the relationship between cyst/oocyst
concentration in drinking water and waterborne disease
P. Wallis
(Canada)
10.20
Genotype analysis for investigation of potential
human-to-animal transmission of Cryptosporidiosis and Giardiasis
through agricultural use of reclaimed wastewater
G. Di Giovanni
(USA)
10.40
Break
Chair: P. Wallis (Canada)
11.00
Removal of Cryptosporidium and Giardia by water treatment
processes
M. LeChevallier (USA)
11.20
UV
and Chemical Inactivation of Cryptosporidium and Giardia in Drinking
Water Treatment - Compilation of Research at University of
Alberta
S.A. Craik
(Canada)
11.40
Data analysis UK CryptoReg data
D.
Drury
12.00
Outlook on Cryptosporidium in drinking water
J. Colbourne
12.40
Lunch with poster presentations
Chair: M. LeChevallier (USA)
13.40
Detection of Giardia and Cryptosporidium in water
P. Karanis (Germany)
14.00
Monitoring of foodstuffs for Cryptosporidium and
Giardia
N. Cook (United
Kingdom)
14.20
Investigation of the survival of Cryptosporidium in
environmental waters
P. Monis
(Australia)
14.40
Survival and development of Cryptosporidium parvum in
water
A. Boxell (Australia)
15.00
Discussion
15.20
Break
15.50
Symposium conclusions
16.30
Closing ceremony with drinks
[ Download/View File ]
|